"Europapress": Ideeea Tx announces AGAcell, a preclinical investigational cell therapy program for alopecia

Ideeea Tx announces AGAcell, a preclinical investigational cell therapy program for alopecia

Ideeea Therapeutics closes a €2.3 million seed funding round to drive the development of advanced therapy medicinal products (ATMPs) with an open science approach and strong clinical impact.